[
1. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 2001; 19: 2886-97.10.1200/JCO.2001.19.11.2886
]Search in Google Scholar
[
2. Shortt K, Davidsson L, Hendry J, Dondi M, Andreo P. International perspectives on quality assurance and new techniques in radiation medicine: outcomes of an IAEA conference. Int J Radiat Oncol Biol Phys 2008; 71: S80-4.10.1016/j.ijrobp.2007.07.2390
]Search in Google Scholar
[
3. Cerezo L, Ciria JP, Arbea L, Linan O, Cafiero S, Valentini V, et al. Current treatment of rectal cancer adapted to the individual patient. Rep Pract Oncol Radiother 2013; 18: 353-62.10.1016/j.rpor.2013.08.005
]Search in Google Scholar
[
4. Cionini L, Gardani G, Gabriele P, Magri S, Morosini PL, Rosi A, et al. Quality indicators in radiotherapy. Radiother Oncol 2007; 82: 191-200.10.1016/j.radonc.2006.12.009
]Search in Google Scholar
[
5. Working Group “Assicurazione di Qualità in Radioterapia” of the Istituto Superiore di Sanità, editor. [Indications for quality assurance in conformal radiotherapy in Italy]. [Italian]. Rapporti ISTISAN 04/34. 2004. p. 54.
]Search in Google Scholar
[
6. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81.10.1016/j.ejca.2009.12.014
]Search in Google Scholar
[
7. Malicki J, Litoborski M, Bogusz-Czerniewicz M, Swiezewski A. Costeffectiveness of the modifications in the quality assurance system in radiotherapy in the example of in-vivo dosimetry. Phys Med 2009; 25: 201-6.10.1016/j.ejmp.2009.02.001
]Search in Google Scholar
[
8. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003; 15: 523-30.10.1093/intqhc/mzg081
]Search in Google Scholar
[
9. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen Y-J, Choti MA, Cooper HS, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw 2009; 7: 838-81.10.6004/jnccn.2009.0057
]Search in Google Scholar
[
10. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52: 929-36.10.1016/S0360-3016(01)02606-2
]Search in Google Scholar
[
11. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 2008; 87: 3-16.10.1016/j.radonc.2007.11.01618160158
]Search in Google Scholar
[
12. Korsgaard M, Pedersen L, Laurberg S. Delay of diagnosis and treatment of colorectal cancer: a population-based Danish study. Cancer Detect Prev 2008; 32: 45-51.10.1016/j.cdp.2008.01.001
]Search in Google Scholar
[
13. Duff SE, Wood C, McCredie V, Levine E, Saunders MP, O’Dwyer ST. Waiting times for treatment of rectal cancer in North West England. J R Soc Med 2004; 97: 117-8.10.1177/014107680409700304
]Search in Google Scholar
[
14. Fesinmeyer MD, Mehta V, Blough D, Tock L, Ramsey SD. Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 78: 675-81.10.1016/j.ijrobp.2009.08.004
]Search in Google Scholar
[
15. Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 2007; 68: 654-61.10.1016/j.ijrobp.2007.03.010
]Search in Google Scholar
[
16. Conde S, Borrego M, Teixeira T, Teixeira R, Sa A, Soares P. Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: prognostic factors. Rep Pract Oncol Radiother 2013; 18: 67-75.10.1016/j.rpor.2012.07.010
]Search in Google Scholar
[
17. Tremblay D, Roberge D, Cazale L, Touati N, Maunsell E, Latreille J, et al. Evaluation of the impact of interdisciplinarity in cancer care. BMC Health Serv Res 2011; 11: 144.10.1186/1472-6963-11-144
]Search in Google Scholar
[
18. Jones WE 3rd, Thomas CR Jr, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, et al. ACR appropriateness criteria: resectable rectal cancer. Radiat Oncol 2012; 7: 161.10.1186/1748-717X-7-161
]Search in Google Scholar
[
19. Mihaylova I, Parvanova V, Velikova C, Kurteva G, Ivanova D. Degree of tumor regression after preoperative chemo-radiotherapy in locally advanced rectal cancer-Preliminary results. Rep Pract Oncol Radiother 2011, 16: 233-8.10.1016/j.rpor.2011.06.008
]Search in Google Scholar
[
20. Molinari C, Ballardini M, Teodorani N, Giannini M, Zoli W, et al. Genomic alterations in rectal cancer tumors and response to neoadjuvant chemioradiotherapy; an exploratory study. Radiat Oncol 2011; 6: 161.10.1186/1748-717X-6-161
]Search in Google Scholar
[
21. Bogusz-Osawa M, Osawa T. The influence of the European and Polish acts of law, regulations and standards on the forms and the contents of the informed consent for oncological treatments. Rep Pract Oncol Radiother 2005; 10: 1-10.10.1016/S1507-1367(05)71111-1
]Search in Google Scholar
[
22. Byrne DJ, Napier A, Cuschieri A. How informed is signed consent? Br Med J (Clin Res Ed) 1988; 296: 839-40.
]Search in Google Scholar
[
23. Malicki J. The importance of accurate treatment planning, delivery, and dose verification. Rep Pract Oncol Radiother 2012; 17: 63-5.10.1016/j.rpor.2012.02.001386326124377001
]Search in Google Scholar
[
24. Richetti A, Fogliatta A, Clivo A, Nicolin G, Pesce G, et al. Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol 2010; 5: 14.10.1186/1748-717X-5-14283892020170490
]Search in Google Scholar
[
25. Saminathan S, Chandraraj S, Sridhar CH, Manickam R. Comparison of individual and composite field analysis using array detector for Intensity Mosulated Radiotherapy dose verification. Rep Pract Oncol Radiother 2012; 17: 157-62.10.1016/j.rpor.2012.03.004386324924377018
]Search in Google Scholar
[
26. Edwards CR, Mountford PJ. Characteristics of in vivo radiotherapy dosimetry. Br J Radiol 2009; 82: 881-3.10.1259/bjr/3256377719752169
]Search in Google Scholar
[
27. Edwards CR, Hamer E, Mountford PJ, Moloney AJ. An update survey of UK in vivo radiotherapy dosimetry practice. Br J Radiol 2007; 80: 1011-4.10.1259/bjr/1494515617967849
]Search in Google Scholar
[
28. Williams MV, McKenzie A. Can we afford not to implement in vivo dosimetry? Br J Radiol 2008; 81: 681-4.
]Search in Google Scholar
[
29. The Royal College of Radiologists. Towards safer radiotherapy. BFCO(08). London: Royal College of Radiologists; 2008. Available from: https://www.rcr.ac.uk/docs/oncology/pdf/Towards_saferRT_final.pdf.
]Search in Google Scholar
[
30. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30.10.1136/bmj.318.7182.527111497310024268
]Search in Google Scholar
[
31. Guedea F, Malicki J. Quality indicators in radiation oncology: in regard to Albert and Das. Int J Radiat Oncol Biol Phys 2013; 87: 432.10.1016/j.ijrobp.2013.06.206024074912
]Search in Google Scholar
[
32. Ishikura S. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care. Jpn J Clin Oncol 2008; 38: 723-9.10.1093/jjco/hyn11218952706
]Search in Google Scholar
[
33. Savatta SG, Temple L. Quality of life in patients treated for curable rectal cancer. Semin Colon Rectal Surg 2005; 16: 170-80.10.1053/j.scrs.2005.09.009
]Search in Google Scholar
[
34. International Atomic Energy Agency. International basic safety standards for protection against ionizing radiation and for the safety of radiation sources. IAEA Safety Series No. 115. Vienna: IAEA; 1996.
]Search in Google Scholar
[
35. Di Genesio Paglica M, Turri L, Munoz F, Melano A, Bacigalupo A, Franzone P, et al. Patterns of practice in the radiation therapy management of rectal cáncer: survey of the Interregional Group Piedmont, Valle d’Aosta and Liguria of the “Associazione Italiana di Radioterapia Oncologica (AIRO). Tumori 2013; 99: 61-7. 10.1177/030089161309900111
]Search in Google Scholar
